← Back to directory

Carlos López

Researcher Next ID · RN-043827

Researcher · Medicine

University of Kentucky

Lexington, Mexico

Accepting doctoral researchersFunding unknown
Works count
313
Citation count
12,041
H-index
45
i10-index
104

Research interests

Medicine
Neuroendocrine Tumor Research Advances
Lung Cancer Research Studies
Colorectal Cancer Treatments and Studies
Pancreatic and Hepatic Oncology Research
Lung Cancer Treatments and Mutations

Publications

  • The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

    Nature Cancer · 2022 · https://doi.org/10.1038/s43018-022-00332-x

  • Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

    Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03368

  • Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial

    ˜The œLancet. Gastroenterology & hepatology · 2021 · https://doi.org/10.1016/s2468-1253(21)00110-2

  • Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal

    Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-0969-2

  • Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

    The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)30207-1

  • Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30146-3

  • Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)

    The Oncologist · 2018 · https://doi.org/10.1634/theoncologist.2017-0364

  • Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

    British Journal of Cancer · 2017 · https://doi.org/10.1038/bjc.2017.245

  • Phase III trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC).

    Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.35.15_suppl.4001

  • Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

    Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx112

  • Digital Sensing and Sizing of Vesicular Stomatitis Virus Pseudotypes in Complex Media: A Model for Ebola and Marburg Detection

    ACS Nano · 2014 · https://doi.org/10.1021/nn501312q

  • LED-based Interferometric Reflectance Imaging Sensor for quantitative dynamic monitoring of biomolecular interactions

    Biosensors and Bioelectronics · 2010 · https://doi.org/10.1016/j.bios.2010.09.038

  • High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

    International Journal of Radiation Oncology*Biology*Physics · 2005 · https://doi.org/10.1016/j.ijrobp.2005.02.010

  • PKCϵ is involved in JNK activation that mediates LPS-induced TNF-α, which induces apoptosis in macrophages

    American Journal of Physiology-Cell Physiology · 2003 · https://doi.org/10.1152/ajpcell.00228.2003

Current projects

    No projects listed.